DekaBank Deutsche Girozentrale’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-50,100
| Closed | -$133K | – | 1422 |
|
|
2020
Q4 | $133K | Hold |
50,100
| – | – | ﹤0.01% | 1243 |
|
|
2020
Q3 | $164K | Buy |
+50,100
| New | +$164K | ﹤0.01% | 1072 |
|
|
2019
Q4 | – | Sell |
-51,900
| Closed | -$114K | – | 1275 |
|
|
2019
Q3 | $114K | Sell |
51,900
-51,900
| -50% | -$114K | ﹤0.01% | 902 |
|
|
2019
Q2 | $317K | Sell |
103,800
-57,810
| -36% | -$177K | ﹤0.01% | 966 |
|
|
2019
Q1 | $386K | Buy |
161,610
+109,710
| +211% | +$262K | ﹤0.01% | 957 |
|
|
2018
Q4 | $141K | Sell |
51,900
-109,710
| -68% | -$298K | ﹤0.01% | 1020 |
|
|
2018
Q3 | $386K | Hold |
161,610
| – | – | ﹤0.01% | 979 |
|
|
2018
Q2 | $375K | Sell |
161,610
-32,000
| -17% | -$74.3K | ﹤0.01% | 971 |
|
|
2018
Q1 | $571K | Sell |
193,610
-2,000
| -1% | -$5.9K | ﹤0.01% | 844 |
|
|
2017
Q4 | $549K | Hold |
195,610
| – | – | ﹤0.01% | 802 |
|
|
2017
Q3 | $549K | Hold |
195,610
| – | – | ﹤0.01% | 809 |
|
|
2017
Q2 | $498K | Buy |
195,610
+98,210
| +101% | +$250K | ﹤0.01% | 834 |
|
|
2017
Q1 | $210K | Sell |
97,400
-8,000
| -8% | -$17.2K | ﹤0.01% | 840 |
|
|
2016
Q4 | $227K | Buy |
105,400
+8,000
| +8% | +$17.2K | ﹤0.01% | 803 |
|
|
2016
Q3 | $315K | Hold |
97,400
| – | – | ﹤0.01% | 756 |
|
|
2016
Q2 | $304K | Buy |
97,400
+29,000
| +42% | +$90.5K | ﹤0.01% | 781 |
|
|
2016
Q1 | $217K | Sell |
68,400
-15,000
| -18% | -$47.6K | ﹤0.01% | 840 |
|
|
2015
Q4 | $298K | Buy |
83,400
+1,000
| +1% | +$3.57K | ﹤0.01% | 799 |
|
|
2015
Q3 | $414K | Buy |
82,400
+3,000
| +4% | +$15.1K | 0.01% | 730 |
|
|
2015
Q2 | $511K | Buy |
79,400
+3,000
| +4% | +$19.3K | 0.01% | 695 |
|
|
2015
Q1 | $537K | Sell |
76,400
-9,500
| -11% | -$66.8K | 0.01% | 698 |
|
|
2014
Q4 | $662K | Sell |
85,900
-8,000
| -9% | -$61.7K | 0.01% | 637 |
|
|
2014
Q3 | $701K | Buy |
93,900
+2,000
| +2% | +$14.9K | 0.01% | 578 |
|
|
2014
Q2 | $890K | Buy |
91,900
+5,500
| +6% | +$53.3K | 0.01% | 517 |
|
|
2014
Q1 | $718K | Buy |
86,400
+6,500
| +8% | +$54K | 0.01% | 523 |
|
|
2013
Q4 | $677K | Buy |
79,900
+1,500
| +2% | +$12.7K | 0.01% | 505 |
|
|
2013
Q3 | $625K | Buy |
+78,400
| New | +$625K | 0.01% | 519 |
|